These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21898494)

  • 21. Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers.
    Mitry RR; De Bruyne R; Quaglia A; Hughes RD; Dhawan A
    Hepatology; 2007 Dec; 46(6):2047-8; author reply 2048. PubMed ID: 18046726
    [No Abstract]   [Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harrison SA; Neuschwander-Tetri BA
    Clin Liver Dis; 2004 Nov; 8(4):861-79, ix. PubMed ID: 15464659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity.
    Lassailly G; Caiazzo R; Hollebecque A; Buob D; Leteurtre E; Arnalsteen L; Louvet A; Pigeyre M; Raverdy V; Verkindt H; Six MF; Eberle C; Patrice A; Dharancy S; Romon M; Pattou F; Mathurin P
    Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):499-506. PubMed ID: 21499110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease.
    Schwimmer JB; Deutsch R; Rauch JB; Behling C; Newbury R; Lavine JE
    J Pediatr; 2003 Oct; 143(4):500-5. PubMed ID: 14571229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non alcoholic steatohepatitis: an emergent and potentially serious pathology].
    Elloumi H; Arfaoui D; Joudène M; Sriha B; Korbi M; Ajmi S
    Tunis Med; 2004 Jun; 82(6):484-91. PubMed ID: 15517946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic fatty liver disease.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2002; 2(1):11-9. PubMed ID: 12122975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The influence and prevalence of nonalcoholic steatohepatitis in chronic hepatitis B].
    Pîrvulescu I; Suciu S; Andrei M; Lupu A; Diculescu M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):91-6. PubMed ID: 21688564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and therapy of nonalcoholic steatohepatitis.
    Torres DM; Harrison SA
    Gastroenterology; 2008 May; 134(6):1682-98. PubMed ID: 18471547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease.
    Palekar NA; Naus R; Larson SP; Ward J; Harrison SA
    Liver Int; 2006 Mar; 26(2):151-6. PubMed ID: 16448452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease.
    Brunt EM; Ramrakhiani S; Cordes BG; Neuschwander-Tetri BA; Janney CG; Bacon BR; Di Bisceglie AM
    Mod Pathol; 2003 Jan; 16(1):49-56. PubMed ID: 12527713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis.
    Koruk M; Tayşi S; Savaş MC; Yilmaz O; Akçay F; Karakök M
    Turk J Gastroenterol; 2003 Mar; 14(1):12-7. PubMed ID: 14593532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: an aid to diagnosis.
    Fletcher LM; Kwoh-Gain I; Powell EE; Powell LW; Halliday JW
    Hepatology; 1991 Mar; 13(3):455-9. PubMed ID: 1999316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
    Nugent C; Younossi ZM
    Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):432-41. PubMed ID: 17667992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of triglyceride and insulin resistance in patients with nonalcoholic steatohepatitis.
    Basaranoglu M
    Can J Gastroenterol; 2002 Nov; 16(11):813-4; author reply 814. PubMed ID: 12464976
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance.
    Yilmaz Y; Ulukaya E; Atug O; Dolar E
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1247-51. PubMed ID: 19474742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One step at a time: identification and validation of biomarkers for nonalcoholic steatohepatitis.
    Talwalkar JA
    Hepatology; 2009 Oct; 50(4):1000-3. PubMed ID: 19787817
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nonalcoholic steatohepatitis].
    da Silva PM; Eliseu T; Costa MM; Bastos H; Nobre FL
    Acta Med Port; 1995 May; 8(5):323-7. PubMed ID: 7625233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
    Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.